Thyroid Hormone Promotes β-Catenin Activation and Cell Proliferation in Colorectal Cancer
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Thyroid hormone status has long been implicated in cancer development. Here we investigated the role of thyroxine (T 4) in colorectal cancer cell lines HCT 116 (APC wild type) and HT-29 (APC mutant), as well as the primary cultures of cancer cells derived from patients. Cell proliferation was evaluated with standard assay and proliferation marker expression. β-Catenin activation was examined according to nuclear β-catenin accumulation and β-catenin target gene expression. The results showed that T 4 increased colorectal cancer cell proliferation while cell number and viability were elevated by T 4 in both established cell lines and primary cells. Moreover, the transcriptions of proliferative genes PCNA, CCND1, and c-Myc were enhanced by T 4 in the primary cells. T 4 induced nuclear β-catenin accumulation, as well as high cyclin D1 and c-Myc levels compared to the untreated cells. In addition, the β-catenin-directed transactivation of CCND1 and c-Myc promoters was also upregulated by T 4. CTNNB1 transcription was raised by T 4 in HCT 116, but not in HT-29, while the boosted β-catenin levels were observed in both. Lastly, the T 4-mediated gene expression could be averted by the knockdown of β-catenin. These results suggested that T 4 promotes β-catenin activation and cell proliferation in colorectal cancer, indicating that an applicable therapeutic strategy should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, T4 stimulates growth of cancer cells and tumors independently of either TRα or TRβ through αvβ3, the type 4 noncanonical pathway (Supplementary Table S3) (30–32).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, T4 stimulates growth of cancer cells and tumors independently of either TRα or TRβ through αvβ3, the type 4 noncanonical pathway (online suppl. Table 3) [30-32].”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Bergh, J. J., Lin, H.-Y., Lansing, L., Mohamed, S. N., Davis, F. B., Mousa, S., & Davis, P. J. (2005) · Endocrinology · doi:10.1210/en.2005-0102 · Cited by 497
Self-citationChromatin Immunoprecipitation (ChIP)
Carey, M. F., Peterson, C. L., & Smale, S. T. (2009) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot5279 · Cited by 258
Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective
Moeller, L. C., & Führer, D. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-12-0219 · Cited by 184 · cited 3×
“Instead of classical genomic actions directed by the T3-bound thyroid hormone receptors (TRα and TRβ), the cancerpromoting effects of thyroid hormones are mostly related to their cell surface receptor integrin αvβ3 and the function of circulating T4 [2, 3].”
BackgroundRORα Attenuates Wnt/β-Catenin Signaling by PKCα-Dependent Phosphorylation in Colon Cancer
Lee, J. M., Kim, I. S., Kim, H., Lee, J. S., Kim, K., Yim, H. Y., Jeong, J., Kim, J. H., Kim, J.-Y., Lee, H., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2009.12.022 · Cited by 179
Arqués, O., Chicote, I., Puig, I., Tenbaum, S. P., Argilés, G., Dienstmann, R., Fernández, N., Caratù, G., Matito, J., Silberschmidt, D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3081 · Cited by 178
Thyroid Function and Cancer Risk: A Prospective Population Study
Hellevik, A. I., Åsvold, B. O., Bjøro, T., Romundstad, P. R., Nilsen, T. I. L., & Vatten, L. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0911 · Cited by 178
Plateroti, M., Kress, E., Mori, J. I., & Samarut, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3204-3214.2006 · Cited by 126
Kress, E., Rezza, A., Nadjar, J., Samarut, J., & Plateroti, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806548200 · Cited by 125
Cited by
Jonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0720 · Cited by 172
Jonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · European Thyroid Journal · doi:10.1159/000512970 · Cited by 78
Metadata
- Authors
- Lee, Y.-S., Chin, Y.-T., Shih, Y.-J., Nana, A. W., Chen, Y.-R., Wu, H.-C., Yang, Y.-C. S. H., Lin, H.-Y., & Davis, P. J.
- Affiliations
- Taipei Medical University (TW)
- Institute of Cellular and Organismic Biology, Academia Sinica (TW)
- Taipei Medical University Hospital (TW)
- Albany College of Pharmacy and Health Sciences (US)
- Corresponding author
- Lin, Hung-Yun
- Venue
- Hormones and Cancer
- Published
- 2018-01-29
- Volume
- 9
- Issue
- 3
- Pages
- 156-165
- ISSN
- 1868-8497 (ISSN-L)
- 1868-8500
- PMC
- PMC10355916
- OpenAlex
- W2790804857
- Cited by
- 28
- References
- 20
- Citations by year
- 2025: 3 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 7 · 2019: 6 · 2018: 3
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Hormones and Cancer (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology, Taiwan (MOST-103-2632-B-038-001, MOST-104-2314-B-038-046-MY3)
- Ministry of Science and Technology (MOST-105-2320-B-038-006)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Keywords
- thyroid hormones, thyroxine, colorectal cancer, β-catenin activation, cell proliferation, APC mutation, cyclin D1, c-Myc, PCNA, CTNNB1, transcriptional activation, cancer cell lines, primary tumor cells
- MeSH terms
- Humans, Thyroxine, Colorectal Neoplasms, Transcriptional Activation, Gene Expression Regulation, Neoplastic, Genes, myc, Genes, APC, Proliferating Cell Nuclear Antigen, HT29 Cells, Cyclin D1, RNA, Small Interfering, HCT116 Cells, Cell Proliferation, beta Catenin, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thyroid Hormone Promotes β-Catenin Activation and Cell Proliferation in Colorectal Cancer. https://app.cochat.ai/papers/10.1007/s12672-018-0324-y
- The paper
- Lee, Y.-S., Chin, Y.-T., Shih, Y.-J., Nana, A. W., Chen, Y.-R., Wu, H.-C., Yang, Y.-C. S. H., Lin, H.-Y., & Davis, P. J. (2018). Thyroid Hormone Promotes β-Catenin Activation and Cell Proliferation in Colorectal Cancer. Hormones and Cancer. https://doi.org/10.1007/s12672-018-0324-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.